Robotic PCI – Has It Come of Age?
Journal Title: BMH Medical Journal - Year 2016, Vol 3, Issue 3
Abstract
Last issue of the Journal contained an article on the benefits of robotic telesurgery. Now we would like to examine another aspect of robotics in medicine - Robotic enhanced percutaneous coronary intervention (PCI). The first-in-humans pilot clinical trial involving 18 patients was published in 2006. In this study angioplasty guidewire, balloon and stents were navigated by a computerized system. The guidewire could cross the lesion successfully in 17 cases and 15 of these cases could be successfully completed by remote navigation. The remaining 3 cases were completed manually. The proposed advantages of the system was a significantly lower radiation exposure to the operator and possibly more precise positioning of the coronary stent. There was no increase in fluoroscopy time.
Authors and Affiliations
Johnson Francis
Safety in Anaesthesia
From the first reported anaesthesia mishap onwards (Hannah Greener about 170 years ago) anaesthesiologists were always concerned about the safety of their patients. Anaesthesia - related mortality is always an important...
Rhabdomyolysis Due To Hashimoto’s Thyroiditis Aggravated By Asthma Exacerbation
Hashimoto's thyroiditis is the most common form of primary hypothyroidism. Patients may present with muscular manifestations like weakness, stiffness, pain and elevated muscle enzymes. Rhabdomyolysis has been reported in...
Update On Management Of In-hospital Hyperglycemia
Hyperglycemia is regarded as one of the most important poor prognostic factors that adversely affects the treatment response in patients admitted with medical or surgical conditions. The most effective way to treat this...
Effective Parenting – Essential for Best Child Development
Parents have the most important role in the intellectual, physical, emotional, social and academic development of children. Parenting is the process of promoting the development of children from infancy to adulthood. It...
Digoxin Dilemma
Digoxin is a very commonly used drug in patients with systolic heart failure for enhancing cardiac contractility and in patients with supraventricular tachyarrhythmias for ventricular rate control. Due to its varied pres...